SOD-1 transgenic mice as a model for studies of neuroprotection in stroke and brain trauma.
Chan
P H
PH
Department of Neurosurgery, University of California School of Medicine, San Francisco 94143.
Epstein
C J
CJ
Kinouchi
H
H
Kamii
H
H
Imaizumi
S
S
Yang
G
G
Chen
S F
SF
Gafni
J
J
Carlson
E
E
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D001924:Brain Concussion / Q000517:prevention & control*; D001930:Brain Injuries / Q000517:prevention & control*; D002531:Cerebellum / Q000201:enzymology; D002540:Cerebral Cortex / Q000201:enzymology; D002544:Cerebral Infarction / Q000517:prevention & control; D003080:Cold Temperature; D005609:Free Radicals / Q000378:metabolism; D007839:Functional Laterality; D018698:Glutamic Acid / Q000633:toxicity*; D006801:Humans; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D051379:Mice; D008822:Mice, Transgenic; D009498:Neurotoxins / Q000633:toxicity; D012016:Reference Values; D013116:Spinal Cord / Q000201:enzymology*; D013482:Superoxide Dismutase / Q000235:genetics / Q000378:metabolism*
D005609:Free Radicals; D009498:Neurotoxins; D018698:Glutamic Acid; D013482:Superoxide Dismutase